US4479794A
Expired / Lapsed
US
⏱️ 0.0 years remaining
System for intravenous therapy
Assignee: Alza Corp
•
Filing: 1983-10-11
•
Granted: 1984-10-30
•
Expires: 2003-10-11
Abstract
Abstract A parenteral delivery system is disclosed for administering a beneficial agent to a recipient. The system comprises (a) a container of a medical fluid; (b) a primary tubing in communication with the container; (c) a parallel tubing connected to the primary tubing having a formulation chamber connected thereto, the formulation chamber housing a beneficial agent, or a device for delivering a beneficial agent; and (d) a common tubing connected to the primary tubing and the parallel tubing for administering the fluid and the agent to a recipient.
Inventors
- 👤 John Urquhart
- 👤 Felix Theeuwes
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 03:19
CPC Classifications
A; A61; A61M; A61M5/00; A61M5/14; A61M5/1407; A61M5/1409; A61M5/142; A61M5/145; A61M2005/14513
Claims Analysis
Total Claims: 6
Claim 1
Independent Claim
188 words
An administration set for use with a parenteral therapeutic system, the administration set comprising: (a) a primary tube for the flow of a medical fluid therethrough; (b) a parallel tube in fluid communication with the primary tube for the flow of medical fluid therethrough; and, (c) a drug formulation chamber connected to the parallel tube, the chamber comprising: (1) a wall surrounding a lumen; (2) an inlet in the wall that communicates with the parallel tube for admitting fluid into the chamber; (3) a fluid permeable film in the formulation chamber, said film a releasing means formed of a material that releases drug from said chamber in the presence of fluid that enters the chamber; (4) a drug in a pharmaceutically acceptable solid form in the formulation chamber and present in therapeutically effective amount for executing a prescribed thereapeutic beneficial program, said drug initially separated from the film, is contacted by fluid that enters the chamber, and is released from said chamber by the film and the fluid that flows therethrough; and, (5) an outlet in the wall for the flow of fluid containing drug from the chamber.
Claim 2
Dependent Claim
188 words
An administration set for use with a parenteral therapeutic system, the administration set comprising: (a) a primary tube for the flow of a medical fluid therethrough; (b) a parallel tube in fluid communication with the primary tube for the flow of medical fluid therethrough; and, (c) a drug formulation chamber connected to the parallel tube, the chamber comprising: (1) a wall surrounding a lumen; (2) an inlet in the wall that communicates with the parallel tube for admitting fluid into the chamber; (3) a fluid permeable film in the formulation chamber, said film a releasing means formed of a material that releases drug from said chamber in the presence of fluid that enters the chamber; (4) a drug in a pharmaceutically acceptable solid form in the formulation chamber and present in therapeutically effective amount for executing a prescribed thereapeutic beneficial program, said drug initially separated from the film, is contacted by fluid that enters the chamber, and is released from said chamber by the film and the fluid that flows therethrough; and, (5) an outlet in the wall for the flow of fluid containing drug from the chamber.
Claim 3
Dependent Claim
22 words
The administration set for use with the parenteral therapeutic system according to claim 1, wherein the drug in solid form is crystalline.
Claim 4
Dependent Claim
23 words
The administration set for use with the parenteral therapeutic system acording to claim 1, wherein the drug in solid form is a powder.
Claim 5
Dependent Claim
22 words
The administration set for use with the parenteral therapeutic system according to claim 1, wherein the drug in solid form is dried.
Claim 6
Dependent Claim
23 words
The administration set for use with the parenteral therapeutic system according to claim 1, wherein the drug in solid form is a particle.
References Cited (Backward Citations)
CH49781A
Cited
US1654745A
Cited
US2849256A
Cited
US3305446A
Cited
US3993073A
Cited
US3797494A
Cited
US3854480A
Cited
US3995631A
Cited
US3756237A
Cited
US3760984A
Cited
US3948254A
Cited
US3845770A
Cited
US3921636A
Cited
US4177256A
Cited
US3941126A
Cited
US3993072A
Cited
US3993066A
Cited
US4203439A
Cited
US4217894A
Cited
US4233973A
Cited
US4219022A
Cited
US4256104A
Cited
US4256105A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-10-30 | 1988-04-30 | 1988-10-30 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-10-30 | 1992-04-30 | 1992-10-30 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-10-30 | 1996-04-30 | 1996-10-30 | $7700.00 | Window Closed / Lapsed |